ALVO Stock Analysis: Buy, Sell, or Hold?
ALVO - Alvotech Ordinary Shares
$3.70
0.05 (1.37%)
▲
5d:
-12.74%
30d:
+9.47%
90d:
+11.11%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When ALVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ALVO is down 12.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ALVO is down 12.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALVO is currently trading at $3.70, which is considered fair relative to its 30-day fair value range of $3.26 to $4.03. From a valuation perspective, the stock is trading at a premium (Forward PE: 20.7) compared to its historical average (15.7). At these levels, the market is pricing in 9.5% annual earnings growth.
Technical Outlook: Technically, ALVO is in a downtrend. The price is currently testing key support at $3.64. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.83 (+273.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALVO is in a downtrend. The price is currently testing key support at $3.64. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.83 (+273.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.26 -
$4.03
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 273.9% below Wall St target ($13.83)
- BULLISH: Expecting earnings turnaround to 9.5% growth with -20.2% revenue growth
- WARNING: Recommendation downgraded due to -12.7% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$3.26 -
$4.03
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.64
Resistance Level
$4.59
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.67
Wall Street Target
$13.83
(+273.9%)
Revenue Growth (YoY)
-20.2%
Earnings Growth (YoY)
-99.0%
Profit Margin
-14.4%
Valuation Premium vs History
+9.5% premium
PE vs Historical
20.7 vs 15.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.5%
(market-implied from PE analysis)
1-Year Target
$4.05
(+10%)
2-Year Target
$4.44
(+20%)
3-Year Target
$4.86
(+31%)
3-Yr Target (if PE normalizes)
(PE: 21→16)
PE COMPRESSION
$3.69
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 216.8%)
$13.16
(+256%)
Base:
(SPY PE: 20.7, Growth: 216.8%)
$12.49
(+238%)
Bear:
(PE: 15.7, Growth: 216.8%)
$9.48
(+156%)
Share & Embed Analysis
Last updated: June 24, 2026 4:09 AM ET
Data refreshes hourly during market hours. Next update: 5:09 AM
Data refreshes hourly during market hours. Next update: 5:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 60 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 64 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 57 HOLD |
